Tisagenlecleucel

Please request pricing for this article.
Request Pricing

Item number	Size	Datasheet	Manual	SDS	Delivery time	Quantity	Price
TGM-T80981-5mg	5 mg				7 - 10 business days*		-
TGM-T80981-50mg	50 mg				7 - 10 business days*		-

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: Tisagenlecleucel (CTL019), an autologous anti-CD19 chimeric antigen receptor (CAR)... more

Close menu

Product information "Tisagenlecleucel"

Description: Tisagenlecleucel (CTL019), an autologous anti-CD19 chimeric antigen receptor (CAR) T-cell therapy, selectively targets and eradicates CD19-expressing B cells, and is utilized in the study of refractory aggressive diffuse large B-cell lymphoma [1] [2].

Keywords:	CTL019
Supplier:	TargetMol
Supplier-Nr:	T80981

Properties

Application:	Targets B-lymphocyte antigen CD19 (CD19)
Conjugate:	No
Format:	32160702

Database Information

CAS :	1823078-37-0\| Matching products
KEGG ID :	K06465 \| Matching products

Handling & Safety

Storage:	-20°C
Shipping:	+20°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "Tisagenlecleucel"

Write a review